During the past decade, Medycyna Kliniczna conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 17 clinical trials were completed, i.e. on average, 48.6% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 17 clinical trials were completed. i.e. 85% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medycyna Kliniczna" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Pfizer" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Fresenius Kabi SwissBioSim GmbH" with 3 trials sponsored and "Galapagos NV" with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medycyna Kliniczna" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Chiltern International Inc." with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Medycyna Kliniczna" are "Rheumatoid Arthritis" (9 trials), "Arthritis, Psoriatic" (5 trials), "Systemic Lupus Erythematosus" (5 trials), "Atopic Dermatitis" (2 trials) and "Postmenopausal Osteoporosis" (2 trials). Many other conditions were trialed in "Medycyna Kliniczna" in a lesser frequency.

Most popular intervention types in "Medycyna Kliniczna" are "Drug" (33 trials), "Biological" (2 trials), "Other" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Guselkumab" (4 trials), "Baricitinib" (3 trials), "Adalimumab" (2 trials) and "Filgotinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Medycyna Kliniczna" are 32 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Medycyna Kliniczna". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 21 completed trials in Medycyna Kliniczna, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Medycyna Kliniczna, 2 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".